In research funded by the AKC Canine Health Foundation (CHF), Dr. Bruce Smith, VMD, PhD of Auburn University uses biotechnology to convert adenovirus, a common human and canine virus, into a treatment for canine osteosarcoma. Dr. Smith's research reprograms a canine adenovirus to attack tumor cells and was funded by CHF in 2012, nearly two years prior to the recent clinical trial at the Mayo Clinic for human myeloma patients using the measles virus.

View the full article